%0 Journal Article
%A Lopez-Tarruella, Sara
%A Escudero, M J
%A Pollan, Marina
%A Martin, Miguel
%A Jara, Carlos
%A Bermejo, Begoña
%A Guerrero-Zotano, Angel
%A Garcia-Saenz, Jose
%A Santaballa, Ana
%A Alba, Emilio
%A Andres, Raquel
%A Martinez, Purificacion
%A Calvo, Lourdes
%A Fernandez, Antonio
%A Batista, Norberto
%A Llombart-Cussac, Antonio
%A Anton, Antonio
%A Lahuerta, Ainhara
%A de la Haba, Juan
%A Lopez-Vega, Jose Manuel
%A Carrasco, E
%T Survival impact of primary tumor resection in de novo metastatic breast cancer patients (GEICAM/El Alamo Registry).
%D 2019
%U http://hdl.handle.net/10668/14894
%X The debate about surgical resection of primary tumor (PT) in de novo metastatic breast cancer (MBC) patients persists. We explored this approach's outcomes in patients included in a retrospective registry, named El Álamo, of breast cancer patients diagnosed in Spain (1990-2001). In this analysis we only included de novo MBC patients, 1415 of whom met the study's criteria. Descriptive, Kaplan-Meier and Cox regression analyses were carried out. Median age was 63.1 years, 49.2% of patients had single-organ metastasis (skin/soft tissue [16.3%], bone [33.8%], or viscera [48.3%]). PT surgery (S) was performed in 44.5% of the cases. S-group patients were younger, had smaller tumors, higher prevalence of bone and oligometastatic disease, and lower prevalence of visceral involvement. With a median follow-up of 23.3 months, overall survival (OS) was 39.6 versus 22.4 months (HR = 0.59, p 
%K Cancer epidemiology
%K Breast cancer
%~